Will the Welsh Government provide an update with regards to the availability of Alyftrek for treatment of cystic fibrosis on the NHS in Wales?
Answered by Cabinet Secretary for Health and Social Care | Answered on 22/07/2025
The NHS Wales Shared Services Partnership’s Medicines Value Unit is working closely with the manufacturer to finalise the commercial agreement for Alyftrek®. We expect the agreement to be completed shortly, making Alyftrek® the latest in the line of life changing treatments for Cystic Fibrosis already routinely available for patients in Wales.